Delayed
Japan Exchange
02:00:00 2024-05-02 am EDT
5-day change
1st Jan Change
5,380
JPY
-0.74%
-5.25%
-20.77%
Sales 2024 *
181B
1.18B
Sales 2025 *
190B
1.24B
Capitalization
399B
2.61B
Net income 2024 *
19.7B
129M
Net income 2025 *
21.21B
138M
EV / Sales 2024 *
1.78
x
Net cash position
2024
*
76.11B
497M
Net cash position
2025
*
80.83B
528M
EV / Sales 2025 *
1.68
x P/E ratio 2024 *
20.4
x
P/E ratio 2025 *
18.9
x
Employees
3,534
Yield 2024 *
1.91%
Yield 2025 *
1.95%
Free-Float
59.84%
Duration
1 day 1 week 1 month 3 months 6 months 1 year 5 years 10 years
Period
5 minutes 15 minutes 30 minutes 1 hour 1 day 1 week 1 month 1 year
Style
CandleStick End-of-day OHLC Mountain
Dynamic Chart
A second Kobayashi Pharma Japan factory inspected over deaths
Mar. 31
RE
Kobayashi factory searched over deaths possibly linked to supplements
Mar. 29
RE
Kobayashi Pharmaceutical Recalls 'Beni-Koji' Supplement Following Report of Death, Kidney Damage
Mar. 26
MT
Tranche Update on Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 7, 2023.
Nov. 07
CI
Kobayashi Pharmaceutical Co., Ltd's Equity Buyback announced on November 7, 2023, has closed with 1,924,600 shares, for ¥11,999.88 million.
Nov. 07
CI
Kobayashi Pharmaceutical Co., Ltd. acquired Focus Consumer Healthcare, LLC.
23-10-06
CI
Kobayashi Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-10
CI
Organ Technologies Inc announced that it has received funding from Kobayashi Pharmaceutical Co., Ltd.
23-02-09
CI
Tranche Update on Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 1, 2022.
22-11-01
CI
Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback announced on November 1, 2022, has closed with 1,150,602 shares, representing 1.49% for ¥9,991.92 million.
22-11-01
CI
Kobayashi Pharmaceutical Co., Ltd. announces an Equity Buyback for 1,265,800 shares, representing 1.64% for ¥9,999.82 million.
22-11-01
CI
Kobayashi Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
22-10-31
CI
Kobayashi Pharmaceutical Co., Ltd. Provides Earnings Guidance for the Full Year 2022
22-08-04
CI
UBS Adjusts Kobayashi Pharmaceutical's Price Target to 12,600 Yen From 13,100 Yen, Keeps at Buy
22-03-03
MT
Tranche Update on Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on October 28, 2021.
22-02-14
CI
More news
1 day -0.74%
1 week -5.25%
Current month +5.59%
1 month +8.27%
3 months -19.07%
6 months -11.69%
Current year -20.77%
More quotes
Managers
Title Age Since
Chairman
84
62-02-28
Director of Finance/CFO
-
-
President
53
98-02-28
Members of the board
Title Age Since
Director/Board Member
91
08-05-31
President
53
98-02-28
Chairman
84
62-02-28
More insiders
Date
Price
Change
Volume
24-05-02
5,380
-0.74%
1,291,600
24-05-01
5,420
-3.15%
1,571,400
24-04-30
5,596
+0.96%
851,200
24-04-26
5,543
-0.66%
990,600
24-04-25
5,580
-0.61%
817,500
Delayed Quote
Japan Exchange, May 02, 2024 at 02:00 am EDT
More quotes
KOBAYASHI PHARMACEUTICAL CO., LTD. a drug manufacturer. The Company operates in three segments. The Domestic Household Products Manufacturing and Sales segment and Overseas Household Products Manufacturing and Sales segment offer health care, daily necessities, skin care and other products. The Mail Order segment involves in the mail order of dietary supplements, skin care products and others.
More about the company
Last Close Price
5,380
JPY
Average target price
6,898
JPY
Spread / Average Target
+28.22%
Consensus
1st Jan change
Capi.
-20.77% 2.55B +11.81% 386B +10.00% 129B +16.56% 75.4B -16.44% 62.79B -7.73% 45.66B -11.19% 36.09B +10.24% 17.57B +9.03% 14.94B -5.73% 10.78B
Other Personal Products
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1